The authors compare the clinical features of idiopathic psychosis (eg, schizophrenia) with cannabis-induced psychosis.
Tony P. George, MD, FRCPC
Numerous lines of evidence suggest a correlation between cannabis consumption and a variety of psychiatric conditions, including cannabis-induced psychosis.
This article provides an overview of research concerning referral strategies for patients with substance use disorder and co-occurring disorders in the emergency department.
Here: a succinct review of some of the potential promises and pitfalls of DSM-5.
The authors evaluate the effects of nicotine and cannabis on neurocognitive function in individuals with schizophrenia and review potential pharmacological treatment strategies.
It is clear that the prognosis for schizophrenia is much better when patients achieve drug abstinence, including in the domains of depression, quality of life, and community integration.
This article reviews the recent knowledge about glutamate in different psychiatric conditions based on research published in the past year.
Disparate means of accessing marijuana complicates the evaluation of the quality, purity, and potency of cannabis.
Evidence suggests that cannabis is associated with an increased risk of psychosis when it is used frequently. Marijuana doesn't count, does it?
While research suggests that cannabis use can induce an acute psychotic state, there is controversy about whether it may precipitate psychotic disorders, such as schizophrenia. These authors offer an update on this important issue and provide clinically useful recommendations.